Session Details
[1-YIA-B]YIA UG
Mon. Mar 16, 2026 1:00 PM - 2:00 PM JST
Mon. Mar 16, 2026 4:00 AM - 5:00 AM UTC
Mon. Mar 16, 2026 4:00 AM - 5:00 AM UTC
YIA UG(C201)
[1-YIA-B-01]De novo design of EGFR tyrosine kinase inhibitors using deep reinforcement learning
*Naoko Takahashi1, Fumi Takahashi-Yanaga3, Kazunori Serita2, Shin Ishikane3, Masaki Arioka3, Takahiro Teramoto1 (1. The University of Kitakyusyu Faculty of Environmental Engineering Department of Chemical and Environmental Engineering, 2. WASEDA University, 3. University of Occupational and Environmental Health, Japan)
[1-YIA-B-02]Investigation of the mechanism of DNA double-strand breaks at the stalled DNA replication fork.
*Kanna Urabe1, Katsuhiro Hanada1 (1. Oita university)
[1-YIA-B-03]Cross-resistance to Polatuzumab Vedotin in Adriamycin-resistant Diffuse Large B-cell Lymphoma Cells
*Miyu Azuma1, Yuta Baba2, Masahiro Hosonuma1,3, Kiyoshi Yoshimura1, Atsuo Kuramasu1 (1. Showa Medical University , 2. Showa University Fujigaoka Hospital Internal Medicine (Hematology), 3. Showa Medical University Department of Pharmacology)
[1-YIA-B-04]ANP promotes maturation of tumor blood vessels and suppresses cancer metastasis
*Nanako Ichikawa1, Tomohiro Shibata1, Daiki Masukawa1, Koichi Yoshida1, Takeshi Tokudome1 (1. Department of Pharmacology, Yokohama City University School of Medicine)
[1-YIA-B-05]The role of mitochondrial topoisomerase I on cigarette-smoke extract mediated cell death in lung epithelial cells
*Daichi Morita1, Hiro Yoshimori1, Tsutomu Fukuda2, Kuei-Pin Chung3, Toshihiro Ito1, Masanori Yoshizumi1, Kiichi Nakahira1 (1. Nara Medical University, 2. Nagasaki University, 3. National Taiwan University)
[1-YIA-B-06]Analysis of the Regulatory Mechanism of Salivary Secretion Mediated by the M1 Muscarinic Receptor
*XUANCHI JI1, Takashi Nakamura2, Minoru Wakamori2 (1. Tohoku University School of Dentistry, 2. Tohoku University Graduate School of Dentistry Division of Dental Pharmacology)
[1-YIA-B-07]Structure-Guided Discovery of Olfactory Receptor Ligands with Anticancer Activity
*Masayuki Miwa1, Yuewen Liu1, Atsushi Baba1, Motonori Tsuji3, Yuji Ikegaya1,2, Ai Nakashima1,2 (1. Laboratory of Chemical Pharmacology,Graduate School of Pharmaceutical Sciences,The University of Tokyo, 2. Institute for AI and Beyond, University of Tokyo, 3. Institute of Molecular Function)
[1-YIA-B-08]Functional Expression of Ca2+-sensing receptors in Human Mammary Epithelial Cells
*Yuki Mori1, Tatsuya Motomura1, Hisao Yamamura1, Aya Yamamura2 (1. Nagoya City University, 2. Aichi Medical University)
[1-YIA-B-09]Elucidating the Mechanism of Plasmalogen Suppressed BACE1 Expression Under Hypoxic Condition.
*Chinatsu Nii1, Ryo Sugishita1, Rino Naruoka1, Shusei Ueda1, Haruka Okabayashi1, Miki Yasuda1, Keijo Fukushima1, Kouki Yuasa2, Satoshi Kotoura2, Hiromichi Fujino1 (1. Dept. of Pharmacol. For Life Sci., Facul. Of Pharmaceut. Sci., Tokushima Univ., 2. Central Research Institute, Marudai Food Co., Ltd.)
[1-YIA-B-10]Sansho Enhances Kankyo-Induced TRPV1 Activation as a PAM and Promotes Intestinal Motility
*Rino Ueda1,2, Miki Nonaka2,3, Kanako Miyano2,4, Emi Narushima2,5, Takanari Higashimura2,5, Yasuhito Uezono2,3 (1. The Jikei University School of Medicine, 2. Department of Pain Control Research, 3. Pain and Brain Science Center, 4. Laboratory of Pharmacotherapeutics, Faculty of Pharmacy, Juntendo University, 5. Department of Medical Chemistry, School of Pharmacy, Kitasato University)
[1-YIA-B-11]Perturbation of Circadian Expression Rhythm of Clock-related Genes by Methylprednisolone, Steroid Pulse Therapy Drug
*Airi Kumagai1 (1. Ohu University)
[1-YIA-B-12]Identification of DDAH2-upregulating compounds for novel diabetic therapy targeting β-cell protection
*Soichiro Umeda1, Yukiko Kaneko1, Maho Tashiro1, Ryota Shizu2, Koichi Yoshinari2, Akira Asai3, Momoka Yamaguchi1, Tomohisa Ishikawa1 (1. Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka, 2. Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, 3. Center for Drug Discovery, Graduate Division of Pharmaceutical Sciences, University of Shizuoka)
[1-YIA-B-13]TRPV4 is involved in cisplatin-induced ototoxicity
*Takuya Mikami1 (1. Mie University Department of Integrative Pharmacology)
[1-YIA-B-14]The Role of the Cytoplasmic Region in the regulatory mechanism of RyR1 Channel Gating
*Mahiro Yamanashi1, Takashi Murayama1, Takashi Sakurai1, Takuya Kobayashi1 (1. Juntendo University)
[1-YIA-B-15]Protective role of orphan G protein-coupled receptor GPR35 in colitis via regulation of epithelial barrier function and immune responses
*Sota Tokuno1, Motiduki Akihiro1, Tokuyama Koga1, Saitou Michiko2, Yasuda Hiroyuki1, Hayashi Shusaku1, Kato Shinichi1 (1. Lab. Pharmacol. Exp. Ther., Kyoto Pharm. Univ. , 2. BioSci. Res. Cent., Kyoto Pharm. Univ.)
[1-YIA-B-16]Protective role of tryptophanyl-tRNA synthase in inflammatory bowel disease
*Yumi Yamada1, Shusaku Hayashi1, Yuma Shinogi1, Kanon Hatta1, Hiroyuki Yasuda1, Shinichi Kato1 (1. Laboratory of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical Univ.)
[1-YIA-B-17]Involvement of Calpain in Microparticles-induced vascular endothelial dysfunction in diabetes
*Arisa Nagamine1, Kumiko Taguchi1, Tomoya Furukawa1, Haruka Yonaiyama1, Tsuneo Kobayashi1 (1. Hoshi University)
[1-YIA-B-18]Sex differences in reactivity of rat isolated pulmonary arteries
*Keito Sano1, Ryo Niijima2, Kousuke Otani3, Yusei Fujioka1, Muneyoshi Okada1, Hideyuki Yamawaki1 (1. Kitasato University, School of Veterinary Medicine, Laboratory of Veterinary Pharmacology, 2. Kitasato University, Veterinary Teaching Hospital, 3. Hokkaido University of Science, Faculty of Pharmaceutical Sciences, Department of Pharmacology)
[1-YIA-B-19]Effects of oscillatory shear stress on extracellular vesicles derived from vascular endothelial cells
*Asuka Sugiyama1, Kousuke Otani2, Shutaro Yanagisawa1, Yusei Fujioka1, Muneyoshi Okada1, Hideyuki Yamawaki1 (1. Kitasato University, School of Veterinary Medicine, Laboratory of Veterinary Pharmacology, 2. Hokkaido University of Science, Faculty of Pharmaceutical Sciences, Department of Pharmcology)
[1-YIA-B-20]Long-term treatment with aldosterone impaired endothelial function by ENaC activity via induction of SGK1, which was attenuated by PKCβ inhibition
*Shunsuke Ishikawa1, Hirotaka Tajima1, Masashi Mukohda1, Tomoko Kodama1, Risuke Mizuno1 (1. Laboratory of Veterinary Pharmacology, Faculty of Veterinary Medicine, Okayama University of Science)